Published in J Clin Pathol on March 01, 1968
A new method for the determination of fibrinogen in small samples of plasma. J Lab Clin Med (1951) 11.55
The mechanism of clot dissolution by plasmin. J Clin Invest (1959) 7.16
Partial purification and properties of a proteolytic enzyme of human serum. J Biol Chem (1949) 5.97
Studies on enhanced fibrinolytic activity in man. J Clin Invest (1959) 3.93
Fibrinolysis and fibrinolytic activity in man. Physiol Rev (1959) 3.57
Plasma fibrinogen and plasminogen levels in health and in ischaemic heart disease. J Clin Pathol (1966) 1.55
Fibrinogenopenia and fibrinolysis in acute myelogenous leukemia. Ann Intern Med (1955) 1.24
Clinical experiences with 6-aminocaproic acid (6-ACA) as an antifibrinolytic agent. Acta Med Scand (1961) 1.17
Hypofibrinogenaemia without increased fibrinolysis in leukaemia. Lancet (1967) 1.02
Fibrinolytic purpura in acute leukemia. Am J Med (1955) 0.98
Serial fibrinogn determinations in patients with leukemia. Am J Med Sci (1961) 0.85
PLASMINOGEN DEFICIENCY IN HODGKIN'S DISEASE. Scott Med J (1965) 0.79
The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor. J Exp Med (1969) 2.39
Attitudes of patients to clinical teaching. Br J Med Educ (1967) 2.28
Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors. J Clin Invest (1969) 2.14
Postgraduate medical degrees of the University of Aberdeen, 1931-69. Scott Med J (1970) 1.64
Plasma fibrinogen and plasminogen levels in health and in ischaemic heart disease. J Clin Pathol (1966) 1.55
Venous thrombosis following strokes. Lancet (1972) 1.46
Familial thrombosis: inherited deficiency of antithrombin III. Br Med J (1978) 1.40
Studies on the blood fibrinolytic enzyme system following acute myocardial infarction. Clin Sci (1967) 1.26
Further medical education of Aberdeen graduates 1956-58. Br J Med Educ (1969) 1.18
Deep venous thrombosis of the legs after strokes. Part I--incidence and predisposing factors. Br Med J (1976) 1.15
The assay of a plasma component necessary for the generation of a plasminogen activator in the presence of Hageman factor (Hageman factor co-factor). Br J Haematol (1971) 1.12
A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarction. Lancet (1973) 1.11
Serum Mucoproteins and Plasma Fibrinolytic Activity in Coronary-artery Disease. Br Med J (1962) 1.10
Cardiac leiomyosarcoma: primary or secondary? Br Heart J (1968) 1.08
The relationship between platelet aggregation and time interval after venepuncture. Thromb Diath Haemorrh (1974) 1.08
Present employment of University of Aberdeen medical graduates, 1956-58. Lancet (1969) 1.06
Hemodialysis in poisoning with methaqualone and diphenydramine. Lancet (1967) 1.01
The inhibition of urokinase by alpha 2 -macroglobulin. Clin Sci (1973) 0.97
The plasminogen content of thrombi. Thromb Diath Haemorrh (1966) 0.96
Studies on the fibrinolytic enzyme system in obesity. J Clin Pathol (1966) 0.94
The metabolism of Plasmodium berghei, the malaria parasite of rodents. 2. An effect of mepacrine on the metabolism of glucose by the parasite separated from its host cell. Biochem J (1961) 0.93
Evaluation of diagnostic significance of certain symptoms and physical signs in anaemic patients. Br Med J (1969) 0.92
Inhibitors of the fibrinolytic enzyme system in renal disease. Clin Sci (1970) 0.92
Psychogenic purpura. Br Med J (1971) 0.91
Effect of oestriol on platelet adhesiveness and fibrinolysis in men. Lancet (1966) 0.91
Effect of exercise on platelet count, adhesion, and aggregation. Acta Haematol (1974) 0.91
Platelet adhesiveness, coagulation, and fibrinolytic activity in obesity. J Clin Pathol (1972) 0.90
Deep venous thrombosis of the legs after strokes: Part 2-Natural history. Br Med J (1976) 0.90
Factors influencing the prognosis in myelomatosis. Postgrad Med J (1971) 0.90
High incidence of myelomatosis in North-East Scotland. Scott Med J (1973) 0.90
Sequential studies on components of the haemostatic mechanism in pregnancy with particular reference to the development of pre-eclampsia. Br J Obstet Gynaecol (1976) 0.90
Methotrexate and the platelet count. Br J Cancer (1968) 0.88
The inhibition of tissue activator and urokinase by human plasma. Thromb Haemost (1982) 0.88
Coagulation and fibrinolysis in thyroid disease. Acta Haematol (1978) 0.87
Surface-mediated reactions in the formation of thrombin, plasmin and kallikrein. Br Med Bull (1978) 0.87
The inhibition by plasma of urokinase and tissue activator-induced fibrinolysis in pregnancy and the puerperium. Thromb Haemost (1983) 0.86
The fibrinolytic enzyme system in hepatic cirrhosis and malignant metastases. J Clin Pathol (1971) 0.86
Arcus senilis and coronary artery disease. Am Heart J (1965) 0.85
Studies on an inhibitor of plasminogen activators in human platelets. Br J Haematol (1974) 0.85
The contribution of plasma protease inhibitors to antiplasmin activity in man. Clin Sci Mol Med (1976) 0.84
Blood levels of proteinase inhibitors in pre-eclampsia. Br J Obstet Gynaecol (1983) 0.83
Inhibitors of plasminogen activation in human blood. Br J Haematol (1976) 0.83
Blood levels of proteinase inhibitors in pregnancy. Br J Obstet Gynaecol (1982) 0.83
Changes in protease inhibitors after acute myocardial infarction. J Clin Pathol (1976) 0.82
Familial scleroderma. Ann Phys Med (1965) 0.82
The action of antithrombin III on plasmin and activators of plasminogen. Biochim Biophys Acta (1975) 0.82
The thyroid and fibrinolysis. Br Med J (1967) 0.81
Arterio-venous differences in the components of the fibrinolytic enzyme system. Thromb Diath Haemorrh (1966) 0.81
The effect of age on the fibrinolytic enzyme system. J Clin Pathol (1974) 0.80
The influence of the platelet count on the incidence of thrombotic and haemorrhagic complications in polycythaemia vera. Postgrad Med J (1970) 0.80
C1 inactivator level in pregnancy. Thromb Res (1982) 0.80
The influence of alpha-1-antitrypsin on plasmin, urokinase and Hageman factor cofactor. Biochim Biophys Acta (1974) 0.80
Urokinase in iliofemoral venous thrombosis. Br J Surg (1969) 0.79
Properties of a partially purified preparation of a circulating plasminogen activator. Thromb Res (1976) 0.79
Platelet adhesiveness and fibrinolysis after recent cerebro-vascular accidents and their relationship with subsequent deep venous thrombosis of the legs. Thromb Haemost (1976) 0.77
The effect of age upon the coagulation system. J Clin Pathol (1974) 0.77
The fibrinolytic system in pre-eclampsia. J Clin Pathol (1984) 0.77
The effect of prolonged exercise on the components of the blood fibrinolytic enzyme system. J Physiol (1968) 0.76
An evaluation of the diagnostic significance of some symptoms and physical signs in chronic iron-deficiency anaemia. Proc Nutr Soc (1969) 0.76
Changes in coagulation factors following acute myocardial infarction in man. Haemostasis (1976) 0.76
Cerebral nocardiosis. Postgrad Med J (1965) 0.76
The influence of the polyphenols of cider on plasmin and plasminogen activators. Br J Haematol (1985) 0.76
The effeCt of vitamin c supplements on serum cholesterol, coagulation, fibrinolysis and platelet adhesiveness. Atherosclerosis (1975) 0.76
Fibrinolytic capacity of arm and leg veins after femoral shaft fracture and acute myocardial infarction. Br Med J (1975) 0.75
Origin and employment of the medical graduates of the University of Aberdeen 1931-69. Br Med J (1970) 0.75
Effect of local exercise and vessel occlusion on fibrinolytic activity. J Clin Pathol (1977) 0.75
Fibrinolytic activity in malignant disease. J Clin Pathol (1975) 0.75
The fibrinolytic enzyme system in hypertension. J Clin Pathol (1973) 0.75
Biochemistry of the plasmin system. J Clin Pathol Suppl (R Coll Pathol) (1980) 0.75
Thrombocytosis following thrombocytopenia in man. Postgrad Med J (1969) 0.75
Relationships between the haemostatic, complement and kinin-forming systems. Br J Haematol (1973) 0.75
The effect of RA 233 on platelet function in vitro and after administration to man. Scand J Haematol (1974) 0.75
Inhibitors of fibrinolysis in amniotic fluid. Thromb Haemost (1980) 0.75
The influence of cigarette smoking on the plasma fibrinogen concentration. Atherosclerosis (1973) 0.75
The influence of haemoglobin on the fibrinolytic enzyme system. Scand J Haematol (1973) 0.75
Effect of low-density lipoprotein preparations on plasmin. Clin Sci (1973) 0.75
Inhibition of the activated Cls subunit of the first component of complement by antithrombin III in the presence of heparin. Thromb Res (1976) 0.75
The effect of chlorpromazine and antihistamines on human blood platelets in vitro and in vivo. Bibl Anat (1973) 0.75
Interrelations between ABO blood group, plasminogen, alpha1-antitrypsin, alpha2-macroglobulin and the platelet count in blood donors. Acta Haematol (1976) 0.75
Inhibition of the plasminogen activator urokinase by alpha-tocopherol. Acta Haematol (1982) 0.75
The fibrinolytic enzyme system in haematological malignancy. Bibl Anat (1973) 0.75
Studies on the blood fibrinolytic system in congestive cardiac failure. Clin Sci (1973) 0.75
Properties of plasma plasminogen activators [proceedings]. J Physiol (1978) 0.75